TAIKO PHARMACEUTICAL CO LTD (4574) Stock Price & News

4574:TYO

TAIKO PHARMACEUTICAL CO LTD

¥267.00

+1.14%

(+3.00) 1D

Oct 21, 10:25:01 AM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 4574...

Open

¥264

High

¥269

Low

¥263

Mkt. cap

13.52B

Avg. vol.

99.81K

Volume

73.80K

Dividend

1.24%

Quarterly dividend

¥1

Ex-dividend date

Dec 29, 2026

P/E ratio

19.51

52-wk high

¥317

52-wk low

¥246

EPS

¥14

Shares outstanding

14.34M

No. of employees

220

Open

¥264

High

¥269

Low

¥263

Mkt. cap

13.52B

Avg. vol.

99.81K

Volume

73.80K

Dividend

1.24%

Quarterly dividend

¥1

Ex-dividend date

Dec 29, 2026

P/E ratio

19.51

52-wk high

¥317

52-wk low

¥246

EPS

¥14

Shares outstanding

14.34M

No. of employees

220

Related stocks

4578

Otsuka Holdings Co Ltd

GMO GlobalSign Holdings KK

¥2,604.00

+7.38%

2491

ValueCommerce Co., Ltd.

¥443.00

-1.34%

News stories

From web sources and news partners

BusinessToday Malaysia

1 hour ago

Dow Rises 1% As Healthcare Stocks Lead Wall Street Gains

FXEmpire

1 hour ago

Dow Jones Price Forecast: Bulls Eye 57,000 as October 6 Low Remains Key

Traders Union

2 hours ago

George Noble: Energy sector to account for 20% of S&P 500 shareholder payouts

BigGo Finance

3 hours ago

Dow Defies Trend to Gain Over 500 Points and Hit Record High as Money Flees AI Hardware for Pharma and Financials

About TAIKO PHARMACEUTICAL CO LTD

CEO-

Employees220

FoundedNov 18, 1946

Headquarters-

SectorMedical device

Websiteseirogan.co.jp

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	1.82B	2.17B	916.00M	1.72B
Cost of goods sold	777.00M	1.05B	415.00M	882.00M
Cost of revenue	777.00M	1.05B	415.00M	882.00M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	763.00M	986.00M	598.00M	723.00M
Operating expense	763.00M	986.00M	598.00M	723.00M
Total operating expenses	1.54B	2.03B	1.01B	1.60B
Operating income	277.00M	134.00M	-97.00M	115.00M
Other non operating income	1.00M	16.00M	-2.00M	3.00M
EBT including unusual items	439.00M	137.00M	-94.00M	134.00M
EBT excluding unusual items	434.00M	29.00M	-94.00M	134.00M
Income tax expense	49.00M	-117.00M	1.00M	-5.00M
Effective tax rate	11.16%	-85.40%	-1.06%	-3.73%
Other operating expenses	-	-	-	-
Net income	390.00M	254.00M	-95.00M	139.00M
Net profit margin	21.46%	11.72%	-10.37%	8.08%
Earnings per share	-	-	-	-
Interest and investment income	6.00M	3.00M	9.00M	3.00M
Interest expense	-1.00M	-1.00M	-	-1.00M
Net interest expenses	5.00M	2.00M	9.00M	2.00M
Depreciation and amortization charges	-	-	-	-
EBITDA	341.00M	200.25M	-30.75M	189.00M
Gain or loss from assets sale	-	-	-	-

Ask anything